BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36801206)

  • 1. Comment on "Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy".
    Stewart MW
    Am J Ophthalmol; 2023 May; 249():183-184. PubMed ID: 36801206
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy.
    Mohan S; Jain M
    Am J Ophthalmol; 2023 May; 249():187-188. PubMed ID: 36587715
    [No Abstract]   [Full Text] [Related]  

  • 3. Bilateral multifocal central serous chorioretinopathy in endogenous hypercortisolism.
    Wang BZ; Saha N
    Clin Exp Optom; 2011 Nov; 94(6):598-9. PubMed ID: 21668499
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Comment on "Vigorous Physical Activity as a Risk factor for Central Serous Chorioretinopathy".
    Cardillo Piccolino F; Fruttini D; Eandi C; Nicolò M; Mariotti C; Tito S; Lupidi M
    Am J Ophthalmol; 2023 May; 249():185-186. PubMed ID: 36796661
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Comment on: Vigorous Physical Activity as a Risk factor for Central Serous Chorioretinopathy.
    Piccolino FC; Fruttini D; Eandi C; Nicolò M; Mariotti C; Tito S; Lupidi M
    Am J Ophthalmol; 2023 May; 249():189-190. PubMed ID: 36587714
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare association: Cushing disease and central serous chorioretinopathy.
    Clarke C; Smith SV; Lee AG
    Can J Ophthalmol; 2017 Apr; 52(2):e77-e79. PubMed ID: 28457311
    [No Abstract]   [Full Text] [Related]  

  • 7. Central serous retinopathy as presentation of an adrenal adenoma.
    Takkar B; Temkar S; Gaur N; Venkatesh P
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567268
    [No Abstract]   [Full Text] [Related]  

  • 8. Smokestack leak on indocyanine green angiography in acute central serous chorioretinopathy.
    Ayachit A; Kumar V; Raj N; Ayachit G
    Indian J Ophthalmol; 2018 Aug; 66(8):1181-1182. PubMed ID: 30038170
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual peripapillary new vessels in eye with central serous chorioretinopathy.
    Roy R; Saurabh K; Bhende MP; Das D; Jain AB
    Clin Exp Optom; 2015 Nov; 98(6):574-6. PubMed ID: 25944144
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bilateral central serous chorioretinopathy post-COVID-19].
    Mahjoub A; Dlensi A; Romdhane A; Ben Abdesslem N; Mahjoub A; Bachraoui C; Mahjoub H; Ghorbel M; Knani L; Krifa F
    J Fr Ophtalmol; 2021 Dec; 44(10):1484-1490. PubMed ID: 34756744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traumatic central serous chorioretinopathy.
    Steeples L; Sharma V; Mercieca K
    Indian J Ophthalmol; 2015 Jun; 63(6):536-8. PubMed ID: 26265647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy.
    Piccolino FC; Fruttini D; Eandi C; Nicolò M; Mariotti C; Tito S; Lupidi M
    Am J Ophthalmol; 2022 Dec; 244():30-37. PubMed ID: 35948087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central serous chorioretinopathy mimicking as choroiditis.
    Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
    Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
    [No Abstract]   [Full Text] [Related]  

  • 14. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy.
    Matsumoto H; Kishi S; Sato T; Mukai R
    Am J Ophthalmol; 2011 Apr; 151(4):617-623.e1. PubMed ID: 21257153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Imaging-Based Central Serous Chorioretinopathy Classification.
    Chhablani J; Cohen FB;
    Ophthalmol Retina; 2020 Nov; 4(11):1043-1046. PubMed ID: 33131671
    [No Abstract]   [Full Text] [Related]  

  • 16. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Spaide RF
    Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.
    Ge G; Zhang Y; Zhang Y; Xu Z; Zhang M
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):71-77. PubMed ID: 31734720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central Serous Chorioretinopathy after Endoscopic Sinus Surgery.
    Woo HJ; Hwang PH
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):772-773. PubMed ID: 28195007
    [No Abstract]   [Full Text] [Related]  

  • 20. Masqueraders of central serous chorioretinopathy.
    Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
    Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.